RxDoctor Payments Data

Michael Larson

Physician Assistant · Palm Desert, CANPI 1710905195

Payments from drug & device makers

$3,008in general payments, 2019–2025

Across 129 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$639
  • Lilly USA, LLC$273
  • Amgen$265
  • Novo Nordisk$242
  • AstraZeneca$184
  • Daiichi Sankyo Inc.$170
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$3,008100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,008 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban75$67,624
OzempicSemaglutide33$47,452
JardianceEmpagliflozin34$31,913
JanuviaSitagliptin Phosphate30$25,921
XareltoRivaroxaban21$23,419
MounjaroTirzepatide18$20,812
Breo ElliptaFluticasone/Vilanterol30$15,234
TrulicityDulaglutide12$13,151
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog20$13,150
Atorvastatin Calcium516$5,166
Levothyroxine Sodium286$3,585
Wixela InhubFluticasone Propion/Salmeterol33$2,974
Omeprazole165$2,965
Venlafaxine Hcl ErVenlafaxine Hcl29$2,517
Gabapentin160$2,365

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$76$67,62475 claims
Novo NordiskOzempic$242$47,45233 claims
Lilly USA, LLCMounjaro, Trulicity$273$33,96230 claims
Boehringer IngelheimJardiance$134$31,91334 claims
Johnson & JohnsonXarelto$639$23,41921 claims
GSKBreo Ellipta$88$15,23430 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Palm Desert

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →